References
- Bell J. International development of portable inhalers. J Invest Allergol Clin Immunol 1997; 7: 417
- Ganderton D. General factors influencing drug delivery to the lung. Respir Med 1977; 91: 13
- Crompton G K. Dry powder inhalers: advantages and limitations. J Aerosol Med 1991; 4: 151
- Fuller R. The Diskus: a new multidose powder device—efficacy and comparison with Turbohaler. J Aerosol Med 1995; 8: S11, Suppl 2
- Brindley A, Sumby B S, Smith I J, Prime D, Haywood P A, Grant G. Design, manufacture and dose consistency of the serevent diskus inhaler. Pharm Technol January, 1995; 15
- Meakin B J, Cainey J M, Woodcock P M. Simulated “in use” and “misuse” aspects of delivery of terbutaline sulphate from Bricanyl dry powder inhalers. Int f Pharm 1995; 119: 103
- Jashnani R N, Byron P R, Dalby R N. Testing of dry powder aerosol formulations in different environmental conditions. Int J Pharm 1995; 113: 123
- Tseng M, Campbell R G, Newhouse M T. Marked in vitro terbutaline Turbohaler inter lot variability and lung targetable dose attenuation under low flow and high humidity conditions. Respir Crit Care Med 1997; 155: A669
- Rogers D F, Ganderton D. Determining equivalence of inhaled medications—consensus statement from a workshop of the British Association of Lung Research. Respir Med 1995; 89: 253
- Warren S J, Rowe A M, Taylor G. Comparison of the lung deposition of radiolabeled beclomethasone di-proprionate from a novel dry powder inhaler, conventional pressurised metered dose inhaler and MDI with a spacer attachment. Thorax 1997; 52: 181
- Chege J K, Parry-Billings M, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation via two versions of a novel dry powder inhaler (Clickhaler) and a standard pressurized metered dose inhaler (Ventolin). Pharm Pharmacol Commun 1998; 4: 107
- Britton J, Tattersfield A. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax 1984; 39: 597
- Price A H, Clissold S P. Salbutamol in the 1980s: a reappraisal of its clinical efficacy. Drugs 1989; 38: 77
- O'Byrne P M. Clinical comparisons of inhaler systems: what are the important aspects. J Aerosol Med 1995; 8: S39, Suppl 3
- Adams W P, Molzon J A, Singh G JP. Interim guidance for documentation of in vivo bioequivalence of albuterol inhalation aerosols (metered dose inhalers). Food and Drug Administration, Rockville, MD 1994
- Jones R, Morice A H. Inspiratory flow rates through a novel dry powder inhaler (Clickhaler) in paediatric asthmatic patients. Am J Respir Crit Care Med 1998; 157: A124
- Warren S W, Taylor G T. Effect of inhalation flow profiles on the deposition of radiolabelled BDP form a novel dry powder inhaler (DPI, Clickhaler®), a conventional metered dose inhaler (MDI) and MDI plus spacer. Respiratory Drug Delivery VI, R N Dalby, P R Byron, S T Farr. Interpharm Inc., Buffalo Grove, IL 1997
- Newhouse M T, Chambers C, Pratt B, Nantel N P, Parry-Billings M. Clickhaler (a novel DPI) provides similar bronchodilation to pMDI even at low flow rates. Chest 1999; 115: 952